Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized TrialJean‐Marc Nabholtz, Mia von Euler, G. Burton et al.|Journal of Clinical Oncology|2000Cited by 996
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability StudyJacques Bonneterre, Mia von Euler, Beat Thürlimann et al.|Journal of Clinical Oncology|2000Cited by 840